GUARDION HEALTH (GHSI)
(Delayed Data from NSDQ)
$8.00 USD
-0.14 (-1.72%)
Updated May 3, 2024 03:59 PM ET
After-Market: $8.13 +0.13 (1.63%) 6:30 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for GUARDION HEALTH falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 12 | 11 | 7 | 2 | 1 |
Cost Of Goods | 7 | 7 | 4 | 2 | 0 |
Gross Profit | 5 | 5 | 3 | 0 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 10 | 22 | 28 | 8 | 11 |
Income After Depreciation & Amortization | -4 | -17 | -25 | -9 | -10 |
Non-Operating Income | 4 | 3 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 0 | -15 | -25 | -9 | -11 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 0 | -15 | -25 | -9 | -11 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 0 | -15 | -25 | -9 | -11 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -4 | -6 | -12 | -8 | -8 |
Depreciation & Amortization (Cash Flow) | 0 | 11 | 13 | 0 | 2 |
Income After Depreciation & Amortization | -4 | -17 | -25 | -9 | -10 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 1.27 | 1.12 | 0.47 | 0.29 | NA |
Diluted EPS Before Non-Recurring Items | 0.12 | -5.17 | -22.00 | -30.00 | NA |
Diluted Net EPS (GAAP) | 0.12 | -14.15 | -52.00 | -30.00 | -89.98 |
Fiscal Year end for GUARDION HEALTH falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 2.94 | 3.34 | 2.79 | 3.19 |
Cost Of Goods | NA | 1.59 | 1.88 | 1.54 | 1.85 |
Gross Profit | NA | 1.35 | 1.46 | 1.25 | 1.34 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.04 | 2.23 | 2.26 | 2.80 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -0.69 | -0.77 | -1.01 | -1.46 |
Non-Operating Income | NA | 1.38 | 1.15 | -0.16 | 2.00 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 0.42 | 0.37 | -1.17 | 0.53 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 0.42 | 0.37 | -1.17 | 0.53 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 0.42 | 0.37 | -1.17 | 0.53 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 1.29 | 1.27 | 1.27 | 1.27 |
Diluted EPS Before Non-Recurring Items | NA | 0.33 | 0.29 | -0.93 | 0.42 |
Diluted Net EPS (GAAP) | NA | 0.34 | 0.29 | -0.93 | 0.42 |